CN107915694A - 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof - Google Patents

1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof Download PDF

Info

Publication number
CN107915694A
CN107915694A CN201610881616.3A CN201610881616A CN107915694A CN 107915694 A CN107915694 A CN 107915694A CN 201610881616 A CN201610881616 A CN 201610881616A CN 107915694 A CN107915694 A CN 107915694A
Authority
CN
China
Prior art keywords
vortioxetine
dimethyl
hydrochloride
solvent
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610881616.3A
Other languages
Chinese (zh)
Inventor
张俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Fukangren Bio Pharm Tech Co Ltd
Original Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Fukangren Bio Pharm Tech Co Ltd filed Critical Beijing Fukangren Bio Pharm Tech Co Ltd
Priority to CN201610881616.3A priority Critical patent/CN107915694A/en
Publication of CN107915694A publication Critical patent/CN107915694A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof, the present invention is by specific preparation method, and obtained hydrochloric acid Vortioxetine HPLC purity is more than 99.5%, and single contaminant is respectively less than 0.1%;It is a kind of in high yield, inexpensive present invention aims at offer, suitable for the compound Vortioxetine of large-scale industrial production and its synthesis technique of hydrochloride.

Description

1- [2- (2,4- 3,5-dimethylphenyls sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof
Technical field
The present invention relates to Vortioxetine salt and its prepare and purify method, belong to pharmaceutical technology field.
Background technology
Patent CN1319958C discloses compound Vortioxetine (Vortioxetine), its structure is shown below, and changes Scientific name claims to be 1- [2- (2,4- 3,5-dimethylphenyl sulfydryl) phenyl] piperazine, is by Lundbeck (Lindbeck) and military field (Takeda) connection The serotonin transporter inhibitor of research and development is closed, its hydrobromate is ratified to list in September, 2013 through FDA, trade name Brintellix, is clinically used for treatment major depressive and generalized anxiety disorder.
Patent CN101472906B discloses Vortioxetine hydrobromate, hydrochloride, mesylate, maleate shape first Formula, and its synthetic method.Method 1:With the bromo- iodobenzenes of 2-, 2,4- thiophenol dimethyl benzenes, Boc- piperazines in toluene solvant, Under palladium chtalyst, Vortioxetine is synthesized through one kettle way or two step coupling reactions, then with corresponding acid into salt;Method 2:With the bromo- iodine of 2- For benzene, 2,4- thiophenol dimethyl benzenes, piperazine in toluene solvant, under palladium chtalyst, synthesized through one kettle way or two step coupling reactions Vortioxetine.No matter which kind of method, metal palladium complex catalyst is employed, it is expensive, and accessory substance is more, it is not easily-controllable System, synthetic method is unfavorable for cost control and amplification produces.
Patent CN104011034B is disclosed with piperazine, 1- iodos -2,4- dimethyl benzene and 2- bromothiophenols as raw material, Equally it is coupled instead through one kettle way under double (dibenzylideneacetone) palladiums and the catalysis of 2,2 '-bis- (diphenylphosphinos) -1,1 '-dinaphthalenes Vortioxetine should be prepared, then is changed into hydrobromate.Likewise, this method also uses the palladium complex catalyst of costliness.
The content of the invention
It is an object of the invention to provide it is a kind of in high yield, low cost, irrigated suitable for the compound of large-scale industrial production For Xi Ting and its synthesis technique of hydrochloride.
To achieve the above object, the preparation method of hydrochloric acid Vortioxetine provided by the invention, reaction are as follows:
Step is
1) reaction temperature is 60~100 DEG C, 2, the 4- dimethyl benzene sulphur with the o-fluoronitrobenzene shown in Formulas I and shown in Formula II Phenol is raw material, and n,N-Dimethylformamide, dimethyl sulfoxide (DMSO), acetonitrile are solvent, and potassium carbonate, sodium carbonate are acid binding agent, reaction life Into 2- (2,4- dimethyl benzenes sulfenyl) nitrobenzene shown in formula III;
Wherein, the molar ratio of o-fluoronitrobenzene (I) and 2,4- thiophenol dimethyl benzenes (II) is 1~1.5:1;
2) reaction temperature is 20~80 DEG C, and with the 2- (2,4- dimethyl benzene sulfenyl) shown in formula III, nitrobenzene is raw material, second Alcohol, methanol are solvent, and iron powder is reducing agent, 2- (2,4- dimethyl benzene sulfenyl) aniline shown in reaction production IV;
3) reaction temperature is 80~120 DEG C, and with the 2- (2,4- dimethyl benzene sulfenyl) shown in formula IV, aniline is raw material, first Benzene, dimethylbenzene are solvent, with the Vortioxetine hydrochloride shown in two (2- chloroethyls) amine hydrochlorates reaction production V;
The molar ratio of wherein 2- (2,4- dimethyl benzenes sulfenyl) aniline (IV) and two (2- chloroethyls) amine is 1:0.95~ 1.1;
4) Vortioxetine hydrochloride is refined in ethyl acetate/methyl tertiary butyl ether(MTBE) in the mixed solvent, obtains the salt of high-purity Sour Vortioxetine hydrochloride;
Wherein the volume ratio of ethyl acetate and methyl tertiary butyl ether(MTBE) is 1:0.5~3.
The present invention's focuses on, and the Vortioxetine of high-purity is prepared using novel method, is avoided expensive Palladium complex catalyst use, synthesis technique is easy, of low cost, suitable for big production.
The emphasis of the present invention also resides in, and gained hydrochloric acid Vortioxetine purity is more than 99.5%, and maximum list is miscellaneous to be less than 0.1%.
Specific embodiment
Embodiment 1:
By 66.3g o-fluoronitrobenzenes, 65 2,4- thiophenol dimethyl benzenes are added into 400mL n,N-Dimethylformamide, Lower addition powdered potassium carbonate 30g is stirred at room temperature, when 80 DEG C of stirrings 5 of temperature control are small, a small amount of water is added after cooling, is concentrated under reduced pressure;It is surplus Excess obtains dark yellow solid 105g with ethyl acetate/petroleum ether mixed solvent crystallization;
Embodiment 2:
2- (2,4- dimethyl benzene sulfenyl) nitrobenzene 100g of the gained of Example 1, adds into 2L water, adds catalytic amount Ammonium chloride, and iron powder 50g, be warming up to 80 DEG C of reactions 3 it is small when, cooling, filters iron powder, filtrate is transferred to 30% wet chemical In, after stirring, ethyl acetate extraction is added, organic phase concentration, obtains 73g 2- (2,4- dimethyl benzene sulfenyl) aniline;
Embodiment 3:
70g 2- (2,4- dimethyl benzenes sulfenyl) aniline and 55g bis- (2- chloroethyls) amine hydrochlorate are added to 500mL first In benzene, when heating reflux reaction 36 is small, cooling, adds 800mL water and 500mL ethyl acetate, liquid separation, organic phase saturation chlorination Sodium solution washs, anhydrous sodium sulfate drying, filtering, dilute hydrochloric acid tune pH to 2 is added dropwise in filtrate, stirring, separates out solid.Filtering, filter Cake is washed with ethyl acetate, and drying, obtains hydrochloric acid 43g.
Embodiment 4:
The hydrochloric acid Vortioxetine crude product 40g of gained is added into 80mL ethyl acetate, activated carbon is added, is heated to reflux, After heat filtering, it is cooled to room temperature, adds t-butyl methyl ether, stirring separates out crystallization, and filtering, drying, obtain hydrochloric acid Vortioxetine Highly finished product 32g.HPLC purity:99.87%, it is maximum single miscellaneous:0.04%.

Claims (2)

1. a kind of preparation method of high-purity Vortioxetine hydrochloride, reaction process are as follows:
Step is:
1) reaction temperature is 60~100 DEG C, is with the o-fluoronitrobenzene shown in Formulas I and 2, the 4- thiophenol dimethyl benzenes shown in Formula II Raw material, n,N-Dimethylformamide, dimethyl sulfoxide (DMSO), acetonitrile are solvent, and potassium carbonate, sodium carbonate are acid binding agent, react production 2- (2,4- dimethyl benzenes sulfenyl) nitrobenzene shown in III;Wherein, o-fluoronitrobenzene (I) and 2,4- thiophenol dimethyl benzenes (II) Molar ratio be 1~1.5:1;
2) reaction temperature is 20~80 DEG C, with 2- (2,4- dimethyl benzene sulfenyl) nitrobenzene shown in formula III for raw material, ethanol, Methanol is solvent, and iron powder is reducing agent, 2- (2,4- dimethyl benzene sulfenyl) aniline shown in reaction production IV;
3) reaction temperature is 80~120 DEG C, and with the 2- (2,4- dimethyl benzene sulfenyl) shown in formula IV, aniline is raw material, toluene, two Toluene is solvent, with the Vortioxetine hydrochloride shown in two (2- chloroethyls) amine hydrochlorates reaction production V;Wherein 2- (2,4- Dimethyl benzene sulfenyl) molar ratio of aniline (IV) and two (2- chloroethyls) amine is 1:0.95~1.1;
4) Vortioxetine hydrochloride is refined in ethyl acetate/methyl tertiary butyl ether(MTBE) in the mixed solvent, and the hydrochloric acid for obtaining high-purity is irrigated For western spit of fland hydrochloride;Wherein the volume ratio of ethyl acetate and methyl tertiary butyl ether(MTBE) is 1:0.5~3.
2. preparation method according to claim 1, obtained hydrochloric acid Vortioxetine HPLC purity is single miscellaneous more than 99.5% Matter is respectively less than 0.1%.
CN201610881616.3A 2016-10-09 2016-10-09 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof Pending CN107915694A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610881616.3A CN107915694A (en) 2016-10-09 2016-10-09 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610881616.3A CN107915694A (en) 2016-10-09 2016-10-09 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107915694A true CN107915694A (en) 2018-04-17

Family

ID=61892320

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610881616.3A Pending CN107915694A (en) 2016-10-09 2016-10-09 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107915694A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111320592A (en) * 2018-12-17 2020-06-23 天津理工大学 Preparation method of 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl ] piperazine
CN115181077A (en) * 2022-07-27 2022-10-14 安徽峆一药业股份有限公司 Synthetic method of vortioxetine with low impurity content

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103936694A (en) * 2014-04-23 2014-07-23 中国药科大学 Preparation method of antidepressant vortioxetine
WO2016004908A1 (en) * 2014-07-08 2016-01-14 Zentiva, K.S. Method of preparing vortioxetine
WO2016079751A2 (en) * 2014-11-17 2016-05-26 Megafine Pharma (P) Ltd. A process for preparation of vortioxetine and polymorphs thereof
WO2016125191A2 (en) * 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103936694A (en) * 2014-04-23 2014-07-23 中国药科大学 Preparation method of antidepressant vortioxetine
WO2016004908A1 (en) * 2014-07-08 2016-01-14 Zentiva, K.S. Method of preparing vortioxetine
WO2016079751A2 (en) * 2014-11-17 2016-05-26 Megafine Pharma (P) Ltd. A process for preparation of vortioxetine and polymorphs thereof
WO2016125191A2 (en) * 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEVENKA LAPANJA 等: "A Generic Industry Approach To Demonstrate Efficient Purification of Potential Mutagenic Impurities in the Synthesis of Drug Substances", 《ORG. PROCESS RES. DEV.》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111320592A (en) * 2018-12-17 2020-06-23 天津理工大学 Preparation method of 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl ] piperazine
CN115181077A (en) * 2022-07-27 2022-10-14 安徽峆一药业股份有限公司 Synthetic method of vortioxetine with low impurity content
CN115181077B (en) * 2022-07-27 2024-03-29 安徽峆一药业股份有限公司 Synthesis method of vortioxetine with low impurity content

Similar Documents

Publication Publication Date Title
CN109369545B (en) Synthesis process of 2-methyl-5-pyrazine formate
CN108623567A (en) Ao Si replaces the preparation method of Buddhist nun
CN103342649B (en) 3-amino-2,4,6-trinitro-diphenylethylene compounds and preparation method thereof
MXPA98000412A (en) Preparation of 3-hidroxipirazoles n-substitui
CN107915694A (en) 1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof
CN107200705A (en) A kind of preparation method of the indolone derivatives of 3 nitro 2
CN101130499B (en) Method for synthesizing nitryl arylamine compounds
CN103896858B (en) The preparation technology of cytosine
CN107011288B (en) A kind of preparation method of aripiprazole intermediate 1- (2,3- dichlorophenyl) piperazine hydrochloride
CN108164423B (en) Preparation method of naftifine hydrochloride
CN105348285B (en) Low-cost and high-yield adenine preparation method
CN111018782B (en) Preparation method of 9-aminoacridine and derivatives thereof
CN104311377B (en) A kind of synthetic method of biphenyl compound
CN113999171A (en) Synthesis method of high-content dipyrithione
CN103073520B (en) Method for synthesizing 2-phenyl benzothiazole and derivative thereof
CN108840806B (en) Preparation method of benzamide compound
CN106243022A (en) A kind of preparation method of nevirapine intermediate
CN108863900A (en) A kind of preparation method of 5- fluoro indole -2- ketone
CN105198806A (en) Method for synthesizing quinoline by aromatic amine and diketone
CN111320592A (en) Preparation method of 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl ] piperazine
CN105541590B (en) A kind of synthetic method for being fluorinated compound of fluorene class
CN109678741A (en) The preparation method of 4- amino -3- fluobenzoic acid
CN107056781A (en) A kind of synthetic method of the formaldoxime of (E) 5 methyl 1H pyrrolo-es [2,3 b] pyridine 3
CN103864645B (en) A kind of two replacement perfluoroalkyl phthalonitrile compound and preparation method thereof
CN107892668A (en) A kind of synthetic method of quinoline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180417

WD01 Invention patent application deemed withdrawn after publication